BioLife Solutions Reports Third Quarter 2023 Financial Results
Conference call begins at 4:30 p.m. Eastern time today
BOTHELL, Wash., Nov. 9, 2023 /PRNewswire/ — BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene therapy (CGT) and broader biopharma markets, today announced financial results for the third quarter and nine months of 2023.
Related news for (BLFS)
- BioLife Solutions Reports Second Quarter 2025 Financial Results
- BioLife Solutions Makes Strategic Investment in Pluristyx
- BioLife Solutions Reports First Quarter 2025 Financial Results
- BioLife Solutions Acquires PanTHERA CryoSolutions to Advance Leadership as a Pure Play Bioproduction Consumables Company
- BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial Results